PharVision Advisers’s Citi Trends CTRN Stock Holding History

PharVision Advisers’s Portfolio CTRN Stock Details CTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,904	Closed	-$245K	–	237
2025 Q4	$245K	Buy	+5,904	New	+$233K	0.12%	404

Other funds holding CTRN

F1I

Fund 1 Investments Rincon, Puerto Rico $603M AUM 62.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BCP

Bayberry Capital Partners New York $290M AUM 37.97% 1-Year Est. Return

PharVision Advisers's CTRN Position: Q1 2026 in Review

PharVision Advisers sold out of Citi Trends (CTRN) in Q1 2026, closing a stake of 5,904 shares — an estimated $245K sold.

PharVision Advisers first reported a position in CTRN in Q4 2025 and held it in 1 quarter. The position peaked at $245K in Q4 2025. 134 funds tracked by Wall St. Rank hold CTRN as of Q1 2026.

PharVision Advisers reported no remaining Citi Trends position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,904 Citi Trends shares in Q1 2026, an estimated $245K.
PharVision Advisers first reported a position in Citi Trends in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Citi Trends position peaked at $245K in Q4 2025.
134 funds tracked by Wall St. Rank held Citi Trends as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.